About the Authors

Jennifer Headley

jheadley@fhi360.org

Affiliation FHI 360, Durham, North Carolina, United States of America

Ansley Lemons

Affiliation FHI 360, Durham, North Carolina, United States of America

Amy Corneli

Affiliation FHI 360, Durham, North Carolina, United States of America

Kawango Agot

Affiliation Impact Research and Development Organization, Kisumu, Kenya

Khatija Ahmed

Affiliation Setshaba Research Center, Soshanguve, South Africa

Meng Wang

Affiliation FHI 360, Durham, North Carolina, United States of America

Jacob Odhiambo

Affiliation Impact Research and Development Organization, Kisumu, Kenya

Joseph Skhosana

Affiliation Setshaba Research Center, Soshanguve, South Africa

Jenae Tharaldson

Affiliation FHI 360, Durham, North Carolina, United States of America

Lut Van Damme

Current address: The Bill & Melinda Gates Foundation, Seattle, Washington, United States of America

Affiliation FHI 360, Durham, North Carolina, United States of America

Kathleen MacQueen

Affiliation FHI 360, Durham, North Carolina, United States of America

for the FEM-PrEP Study Group

Competing Interests

Gilead Sciences, Inc. donated Truvada and placebo. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceived and designed the experiments: AC K. Agot K. Ahmed LVD. Performed the experiments: K. Agot K. Ahmed JO JS AC LVD. Analyzed the data: JH AL MW JT. Contributed reagents/materials/analysis tools: JH AL AC JT MW. Wrote the paper: JH AL AC KM. Manuscript review and revisions: AL AC KM K. Agot K. Ahmed MW JO JS JT LVD.